News
News Releases
Axcelead DDP’s English Version of Official Website Renewed
We are pleased to announce the renewal of Axcelead DDP's English version of the official website. The...
Axcelead Drug Discovery Partners and Acadia Pharmaceuticals Launch 2nd Drug Discovery Project in Neuroscience
December 25, 2023 – Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; hereinafter referred to as “Axcelead...
In-Vivo Science and Axcelead DDP Entered into Cooperative Agreement for Drug Discovery Services Using Disease Model Animals
In-Vivo Science, Inc. (Headquarters: Meguro-ku, Tokyo; Branch Office: Kawasaki City, Kanagawa Prefecture; President: Koji Yoshimura; hereinafter “In-Vivo...
Results of joint research with the University of Tokyo published in the international scientific journal “Nature Communications”
Axcelead Drug Discovery Partners Inc. (Headquarters: Fujisawa City, Kanagawa Prefecture; President & CEO: Nobuhiko Yamada; hereinafter “Axcelead...
FRONTEO and Axcelead DDP Sign Master Collaboration Agreement for AI Drug Discovery Support Partnership
FRONTEO Inc. (Headquarters: Minato-ku, Tokyo; President & CEO: Masahiro Morimoto; hereinafter “FRONTEO”) and Axcelead Drug Discovery Partners...